From: The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients
 | Transplant stable (n = 13) | Acute antibody mediated acute rejection (n = 8) | Acute rejection (n = 7) | Chronic rejection (n = 7) | ||||
---|---|---|---|---|---|---|---|---|
 | Before | After | Before | After | Before | After | Before | After |
BUN (mmol/L) | 17.5 (7.2–32.8) | 7.4* (3.7–10.6) | 16.2 (10.1–28.4) | 29.1* (22.3–38.9) | 16.2 (14.4–20.6) | 25.2* (17.9–34.7) | 16.5 (9.2–22.6) | 18.3* (13.5–26.8) |
Cr (umol/L) | 779 (499–1790) | 130* (72–352) | 798 (739–1682) | 1387* (1098–1786) | 789 (762–1562) | 987* (794–1682) | 786 (698–1492) | 578* (512–755) |
eGFR (ml/min) | 20 (8–67) | 88* (59–101) | 27 (8–62) | 9* (4–13) | 21 (9–59) | 12* (6–24) | 24 (9–51) | 18* (5–35) |
WBC (×109/L) | 9.8 (8.5–13.4) | 7.9* (6.3–9.7) | 9.7 (8.9–13.9) | 17.7* (11.8–19.6) | 9.6 (8.8–11.6) | 13.1* (9.9–16.2) | 9.7 (8.6–13.2) | 11.7* (9.6–13.7) |
PBMCs (×109/L) | 1.7 (1.1–2.9) | 0.8* (0.6–1.0) | 1.7 (1.3–3.3) | 0.3* (0.1–0.6) | 1.9 (1.4–3.1) | 0.7* (0.4–1.0) | 1.7 (1.1–2.7) | 0.7* (0.9–1.2) |
RBC (×1012/L) | 2.4 (2.1–2.7) | 3.1* (2.6–3.3) | 2.0 (1.7–2.5) | 1.5* (1.3–2.0) | 2.1 (1.9–3.1) | 1.9* (1.7–2.3) | 2.0 (1.9–2.9) | 2.3* (2.0–2.8) |
Hb (g/L) | 86.0 (73.0–99.0) | 97.0* (88.0–103.0) | 82.0 (66.0–91.0) | 73.0* (61.0–77.0) | 87.0 (69.0–103.0) | 78.0* (67.0–89.0) | 84.0 (69.0–107) | 91.0* (80.0–110.0) |